Trade ENVB stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Enveric Biosciences, Inc. (ENVB) is trading at US$1.55, down 0.96% today as of Sep 22, 12:37 EDT. The company has a market capitalisation of US$6.4M. Over the past 52 weeks, ENVB has traded between US$1.17 and US$13.25. On Syfe you can trade ENVB with $0 commission and add it to your watchlist.
| Previous close | US$1.56 |
|---|---|
| Market cap | US$6.4M |
| 52-week range | US$1.17 – US$13.25 |
| Volume | 51.29K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Enveric Biosciences, Inc.
Enveric Biosciences, Inc. is a biotechnology company which engages in the development of neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company was founded on February 28, 1994 and is headquartered in Cambridge, MA.
Year: 1995
Enveric Biosciences Begins Genotoxicity Testing for EB-003
Jun 2, 12:50 PM · MT Newswires
Top Midday Decliners
Apr 17, 5:27 PM · MT Newswires
Enveric Biosciences, Inc. (ENVB) stock is trading at US$1.55, -0.96% from the previous close of US$1.56.
The market cap for Enveric Biosciences, Inc. (ENVB) stock is approximately US$6.4M.
The 52-week high for Enveric Biosciences, Inc. (ENVB) stock is US$13.25.
The 52-week low for Enveric Biosciences, Inc. (ENVB) stock is US$1.17.
Enveric Biosciences, Inc. (ENVB) does not currently pay a dividend.
Stay on top of ENVB
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
